Selective LOXL2 inhibition: potent antifibrotic effects in ongoing fibrosis and fibrosis regression

Gut. 2017 Sep;66(9):1540-1541. doi: 10.1136/gutjnl-2016-313621. Epub 2017 Feb 28.

Authors

Fernando Magdaleno^{1

2}, Jonel Trebicka^{1

3

4}

Affiliations

¹ Department of Internal Medicine I, University of Bonn, Bonn, Germany.
² Department of Pathology, University of Illinois at Chicago, Chicago, Illinois, USA.
³ Institute of Clinical Research, Odense University Hospital, University of Southern Denmark, Odense, Denmark.
⁴ European Foundation for the Study of Chronic Liver Failure, Travessera de Gràcia, Barcelona, Spain.

PMID: 28246311
DOI: 10.1136/gutjnl-2016-313621

No abstract available

Keywords: EXTRACELLULAR MATRIX; FIBROSIS; LIVER CIRRHOSIS.

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Fibrosis*
Humans
Liver Cirrhosis*